Zhejiang Huahai Pharmaceutical Co., Ltd. provided earnings guidance for the first half of 2020. The company predicts that the net profit owned by shareholders of the listed company in the first half of 2020 will be between RMB 552 million and RMB 620 million, with an increase of between 65% and 85% compared with the same period of the year before (based on the disclosed statistics according to relevant regulations). The net profit belonging to shareholders of the listed company after excluding extraordinary profit and loss in the first half of 2020 will be between RMB 502 million and RMB 570 million, with an increase of between 90% and 115% (based on the disclosed statistics according to relevant regulations).